Global Pneumonia Testing Market 2017-2021


#1027801

117pages

Technavio

$ 3500

In Stock

About Pneumonia Testing

Pneumonia is a complicated infection of the lower respiratory tract. It may start on or after an upper respiratory tract infection. Mostly, it affects people with weakened immune systems and is common in children and older people.

Technavios analysts forecast the global pneumonia testing market to grow at a CAGR of 9.91% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global pneumonia testing market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of various diagnostic tests for pneumonia (community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP)) to key end-users such as hospitals, diagnostic laboratories, and homecare.

The market is divided into the following segments based on geography:
Americas
APAC
EMEA

Technavio's report, Global Pneumonia Testing Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
Abbott Molecular
bioMrieux
Becton, Dickenson and Company (BD)
Roche Molecular Diagnostics
Thermo Fisher Scientific

Other prominent vendors
AdvanDx
Alere
Beckman Coulter
Bio-Rad
Cepheid
Concile
Diamedix
DiaSorin
Eiken Chemical
Fast-track diagnostics
Hologic
Meridian Biosciences
Qiagen
Quest Diagnostics
Quidel
SeraCare
Trinity Biotech

Market driver
Increased awareness regarding early diagnosis and preventive measures.
For a full, detailed list, view our report

Market challenge
Limited detection capability and accuracy.
For a full, detailed list, view our report

Market trend
Growing consumer shift toward direct-to-consumer testing.
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2021 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analysts time when you purchase this market report. Details are provided within the report.
Table of Contents

PART 01: Executive summary

PART 02: Scope of the report


Market overview
Top-vendor offerings


PART 03: Market research methodology


Research methodology
Economic indicators


PART 04: Introduction


Key market highlights
Pneumonia: An overview
Market snapshot


PART 05: Market landscape


Market overview
Market size and forecast
Buying criteria
Five forces analysis


PART 06: Market segmentation by product type


Global pneumonia testing market by analyzers
Global pneumonia testing market by consumables


PART 07: Market segmentation by method


Immunodiagnostics
Molecular diagnostics
POC
Global pneumonia testing market by immunodiagnostics
Global pneumonia testing market by molecular diagnostics
Global pneumonia testing market by POC


PART 08: Market segmentation by technology


ELISA
Immunofluorescence
Western blot
PCR
IHC
NASBA
Others
PART 09: Market segmentation by end-user
Hospitals
Diagnostic laboratories
Homecare
Others


PART 10: Geographical segmentation


Pneumonia testing market in the Americas
Pneumonia testing market in EMEA
Pneumonia testing market in APAC


PART 11: Market drivers


Increased awareness regarding early diagnosis and preventive measures
Growing popularity of POC testing
Marketing strategies of vendors
Improvement in healthcare infrastructure


PART 12: Impact of drivers

PART 13: Market challenges


Limited detection capability and accuracy
Presence of an undiagnosed population
Regulatory and economic hurdles


PART 14: Impact of drivers and challenges

PART 15: Market trends


Increase in adoption of molecular diagnostic testing
Growing consumer shift toward direct-to-consumer testing
Shift from monoplex to multiplex testing


PART 16: Vendor landscape


Competitive scenario
Market share analysis
Geographical presence of the key vendors
Key news


PART 17: Key vendor analysis


Abbott Molecular
bioMrieux
BD0
Roche Molecular Diagnostics
Thermo Fisher Scientific
Other prominent vendors


PART 18: Appendix


List of abbreviations


PART 19: Explore Technavio
List of Exhibits

Exhibit 01: Product offerings

Exhibit 02: Global pneumonia testing market by type 2016

Exhibit 03: Global pneumonia testing market: Analysis

Exhibit 04: Yearly prevalence of pneumonia, region wise

Exhibit 05: Market overview: Global pneumonia testing market

Exhibit 06: Global pneumonia testing market 2016-2021 ($ millions)

Exhibit 07: Global pneumonia testing market analysis: Developed and emerging markets

Exhibit 08: Key buying criteria in global pneumonia testing market

Exhibit 09: Buying criteria for pneumonia testing

Exhibit 10: Five forces analysis

Exhibit 11: Global pneumonia testing market segmentation by product type 2016

Exhibit 12: Global pneumonia testing market segmentation by product type 2021

Exhibit 13: Market overview: Global pneumonia testing market by analyzers

Exhibit 14: Global pneumonia testing market by analyzers 2016-2021 ($ millions)

Exhibit 15: Market overview: Global pneumonia testing market by consumables

Exhibit 16: Global pneumonia testing market by consumables 2016-2021 ($ millions)

Exhibit 17: Segmentation of pneumonia testing market by product type 2016-2021 ($ millions)

Exhibit 18: Segmentation of global pneumonia testing market by product type 2016-2021 (%)

Exhibit 19: Global pneumonia testing market by method

Exhibit 20: Global pneumonia testing market segmentation by method 2016

Exhibit 21: Global pneumonia testing market segmentation by method 2021

Exhibit 22: Global pneumonia testing market by immunodiagnostics 2016-2021 ($ millions)

Exhibit 23: Global pneumonia testing market by molecular diagnostics 2016-2021 ($ millions)

Exhibit 24: Global pneumonia testing market by POC 2016-2021 ($ millions)

Exhibit 25: Segmentation of pneumonia testing market by method 2016-2021 ($ millions)

Exhibit 26: Segmentation of pneumonia testing market by product type 2016-2021 (%)

Exhibit 27: Global pneumonia testing market by technology

Exhibit 28: Global pneumonia testing market by technology 2016

Exhibit 29: Global pneumonia testing market segmentation by end-users 2016

Exhibit 30: Global pneumonia testing market segmentation by geography 2016

Exhibit 31: Global pneumonia testing market segmentation by geography 2021

Exhibit 32: Global pneumonia testing market: Country-wise revenue and growth analysis 2016

Exhibit 33: Global pneumonia testing market: Geography lifecycle analysis 2016

Exhibit 34: Market overview: Americas

Exhibit 35: Pneumonia testing market in Americas 2016-2021 ($ millions)

Exhibit 36: Country-wise analysis: Americas

Exhibit 37: Market overview: EMEA

Exhibit 38: Pneumonia testing market in EMEA 2016-2021 ($ millions)

Exhibit 39: Country-wise analysis: EMEA

Exhibit 40: Market overview: APAC

Exhibit 41: Pneumonia testing market in APAC 2016-2021 ($ millions)

Exhibit 42: Country-wise analysis: APAC

Exhibit 43: Global pneumonia testing market segmentation by geography 2016-2021 (%)

Exhibit 44: Global pneumonia testing market segmentation by geography 2016-2021 ($ millions)

Exhibit 45: Geographical overview: Global pneumonia testing market

Exhibit 46: Yearly country-wise death rates per 100,000 population due to pneumonia on average 2015

Exhibit 47: Marketing strategies of global vendors

Exhibit 48: Impact of drivers

Exhibit 49: Recent initiatives taken to combat antibiotic resistance

Exhibit 50: Country-wise regulatory requirements

Exhibit 51: Impact of drivers and challenges

Exhibit 52: Acquisitions by global vendors in 2016

Exhibit 53: Competitive structure analysis of global pneumonia testing market 2016

Exhibit 54: Market penetration of pneumonia testing manufacturers globally (2016)

Exhibit 55: Strategic success factors of companies in global pneumonia testing market 2016

Exhibit 56: Share of vendors in global pneumonia testing market 2016

Exhibit 57: Regional analysis of key vendors 2016

Exhibit 58: Key highlights of Abbott Molecular

Exhibit 59: Abbott Molecular: Strength assessment

Exhibit 60: Abbott Molecular: Strategy assessment

Exhibit 61: Abbott Molecular: Opportunity assessment

Exhibit 62: Key highlights of bioMrieux

Exhibit 63: bioMrieux: Strength assessment

Exhibit 64: bioMrieux: Strategy assessment

Exhibit 65: bioMrieux: Opportunity assessment

Exhibit 66: Key highlights of BD

Exhibit 67: BD: Strength assessment

Exhibit 68: BD: Strategy assessment

Exhibit 69: BD: Opportunity assessment

Exhibit 70: Key highlights of Roche Molecular Diagnostics

Exhibit 71: Roche Molecular Diagnostics: Strength assessment

Exhibit 72: Roche Molecular Diagnostics: Strategy assessment

Exhibit 73: Roche Molecular Diagnostics: Opportunity assessment

Exhibit 74: Key highlights of Thermo Fisher Scientific

Exhibit 75: Thermo Fisher Scientific: Strength assessment

Exhibit 76: Thermo Fisher Scientific: Strategy assessment

Exhibit 77: Thermo Fisher Scientific: Opportunity assessment